No Yes Ok

Archive

Newer Entries »

COVID-19 – Perspective from a Biotech Investor Thursday, March 26th, 2020
by Geraldine O’Keeffe and Mark Wegter   The purpose of this memo is not to try and repeat what so many people – both experts and nonexperts - have been writing and saying for the past weeks and months. Th [...]
LSP’s portfolio company eTheRNA launches SARS-CoV-2 mRNA vaccine program for COVID-19 Wednesday, March 25th, 2020
eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective                                         CoV-2 mRNA Vaccine for High Risk Populations   Amste [...]
LSP closes largest ever European life sciences fund at $600 million Tuesday, March 10th, 2020
Amsterdam, Munich, Boston, 10 March 2020    LSP, the leading life sciences investor in Europe, is pleased to announce that it has held its final close of LSP 6 at the $600 million hard cap. This is the large [...]
Orphazyme completes offering of 7,032,937 shares in a directed issue and private placement Friday, February 7th, 2020
Copenhagen, Denmark, February 7, 2020 – Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces the comple [...]
Atlantic Therapeutics Announces FDA Clearance for Over-the-Counter Use of INNOVO Thursday, February 6th, 2020
February 06, 2020   GALWAY, Ireland--Atlantic Therapeutics, a global medical device manufacturer, today announced that the U.S. Food and Drug Administration (FDA) has granted over-the-counter (OTC) clearance [...]
LSP portfolio company binx announces launch of its pre-order program for the world's first FDA-cleared, rapid molecular point-of-care instrument Monday, January 13th, 2020
binx offers first FDA 510(k) cleared molecular point-of-care solution for test and treat of sexually-transmitted infections in a single visit    BOSTON, Jan. 13, 2020 /PRNewswire/ -- binx health today announ [...]

Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
Follow us

No Yes Ok

Archive

Newer Entries »

COVID-19 – Perspective from a Biotech Investor Thursday, March 26th, 2020
by Geraldine O’Keeffe and Mark Wegter   The purpose of this memo is not to try and repeat what so many people – both experts and nonexperts - have been writing and saying for the past weeks and months. Th [...]
LSP’s portfolio company eTheRNA launches SARS-CoV-2 mRNA vaccine program for COVID-19 Wednesday, March 25th, 2020
eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective                                         CoV-2 mRNA Vaccine for High Risk Populations   Amste [...]
LSP closes largest ever European life sciences fund at $600 million Tuesday, March 10th, 2020
Amsterdam, Munich, Boston, 10 March 2020    LSP, the leading life sciences investor in Europe, is pleased to announce that it has held its final close of LSP 6 at the $600 million hard cap. This is the large [...]
Orphazyme completes offering of 7,032,937 shares in a directed issue and private placement Friday, February 7th, 2020
Copenhagen, Denmark, February 7, 2020 – Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces the comple [...]
Atlantic Therapeutics Announces FDA Clearance for Over-the-Counter Use of INNOVO Thursday, February 6th, 2020
February 06, 2020   GALWAY, Ireland--Atlantic Therapeutics, a global medical device manufacturer, today announced that the U.S. Food and Drug Administration (FDA) has granted over-the-counter (OTC) clearance [...]
LSP portfolio company binx announces launch of its pre-order program for the world's first FDA-cleared, rapid molecular point-of-care instrument Monday, January 13th, 2020
binx offers first FDA 510(k) cleared molecular point-of-care solution for test and treat of sexually-transmitted infections in a single visit    BOSTON, Jan. 13, 2020 /PRNewswire/ -- binx health today announ [...]

Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
X

MONTHLY REPORTS

Here you can subscribe for the monthly report of the LSP Life Sciences Fund